Mark Swofford, DO
NPI 1245238484 · Urology Physician · Pikeville, KY
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1245238484
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- DO
- Sex
- Male
- Sole proprietor
- No
- License
- 02625 (KY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
573 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 405 | $60 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 48 | $76 |
| Initial Hospital Care With Straightforward Or Low Level of Medical Decision Making, Per Day, If Using Time, at Least 40 Minutes99221 | 42 | $78 |
| Diagnostic Exam of Bladder and Urethra Using an Endoscope52000 | 30 | $75 |
| Crushing of Stone of Ureter Using an Endoscope52353 | 13 | $379 |
| Exam of Bladder and Urethra for Treatment of Female Urethral Syndrome Using an Endoscope |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 24 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 1,169 | 288 |
| Finasteride | 870 | 217 |
| Testosterone Cypionate | 534 | 70 |
| Dutasteride | 195 | 44 |
| Alfuzosin Hclbrand: Alfuzosin Hcl Er | 193 | 43 |
| Oxybutynin Chloride | 135 | 45 |
| Nitrofurantoin Macrocrystalbrand: Nitrofurantoin | 111 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$964 across 43 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-07-12
- Last updated
- 2022-06-07
- Certified
- 2022-06-07
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.